To make disease-modifying first-in-class immuno-oncology treatments available to patients suffering from devastating conditions such as cancer

Medibiofarma focused internal resources on areas where lies the experience of the management team:

• Virtual drug design
• Medicinal Chemistry
• In Vitro Pharmacology
• Intellectual Property

The remaining activities needed for the full compound characterization and the nomination of a development candidate, such as in vivo pharmacology and toxicology and IND-enabling studies  are carried out through partnerships with several companies (CROs), Research Centers and Universities.